Suramin and radiotherapy in newly diagnosed glioblastoma: Phase 2 NABTT CNS Consortium study

Suramin is a polysulfonated naphthylurea that inhibits the function of growth factors and growth factor receptors implicated in glioma progression, angiogenesis, and radioresistance. The safety and benefits of combining inhibitors of angiogenesis and growth factors with cytotoxic therapies in patien...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Laterra, John J., Grossman, Stuart A., Carson, Kathryn A., Lesser, Glenn J., Hochberg, Fred H., Gilbert, Mark R.
Format: Artigo
Sprache:Inglês
Veröffentlicht: Duke University Press 2004
Schlagworte:
Clinical Investigations
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC1871972/
https://ncbi.nlm.nih.gov/pubmed/14769135
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1215/S1152851703000127
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge